COSMOS HEALTH INC (COSM)
NASDAQHealth CareMedical - PharmaceuticalsSnapshot 2026-09-04
$0.27+2.59%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - PharmaceuticalsSnapshot 2026-09-04
QuarterlyIQ Insights · COSM
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||
| Revenues | 73.7 | 65.3 | 54.4 | 53.4 | 50.3 | 56.2 | 55.4 | 39.7 | 37.1 | 30.0 | 6.8 | 0.5 | 7.6 | 0.9 | — |
| Total Revenues | 73.7 | 65.3 | 54.4 | 53.4 | 50.3 | 56.2 | 55.4 | 39.7 | 37.1 | 30.0 | 6.8 | 0.5 | 7.6 | 0.9 | — |
| Cost of Revenues | 66.2 | 57.4 | 50.1 | 49.0 | 44.4 | 47.9 | 47.3 | 36.0 | 34.7 | 28.1 | 6.2 | 0.5 | — | — | — |
| Gross Profit | 7.6 | 7.9 | 4.3 | 4.3 | 6.0 | 8.3 | 8.1 | 3.7 | 2.4 | 2.0 | 0.6 | 0.0 | — | — | — |
| Operating Expenses & Income | |||||||||||||||
| R&D Expenses | — | 0.5 | 0.5 | 0.2 | — | — | — | — | — | — | — | — | — | — | — |
| Other Operating Expenses, Total | — | — | — | — | — | (0.1) | 0.0 | — | (7.8) | (1.3) | (0.4) | (6.2) | (0.1) | (0.0) | — |
| Operating Income | (18.3) | (16.7) | (15.5) | (21.8) | (7.5) | (4.5) | 2.7 | (0.3) | (1.2) | (4.9) | (0.2) | (0.4) | 7.1 | 0.3 | (0.3) |
| Earnings from Continuing Operations | |||||||||||||||
| Interest Expense | 2.3 | 1.9 | 1.0 | 0.9 | 2.3 | 2.8 | 2.8 | (1.4) | (1.0) | 0.7 | 0.2 | 0.1 | — | — | — |
| Interest & Investment Income | — | — | — | — | — | — | 0.1 | — | — | — | — | — | — | — | 0.0 |
| Net Interest Expenses | — | — | — | — | — | — | 2.7 | — | — | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | (6.1) | (2.4) | (0.6) | 3.3 | (5.6) | (3.3) | (1.5) | — | — | — | — | — | — | — | — |
| Asset Writedown | — | 0.2 | 0.3 | 0.0 | — | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | (24.4) | (19.1) | (16.2) | (18.5) | (13.1) | (7.8) | 1.2 | (3.1) | (9.0) | (6.2) | (0.6) | (6.7) | 7.0 | 0.3 | — |
| Income Tax Expense | — | — | — | 0.0 | (0.8) | 0.1 | (0.4) | 0.2 | (0.0) | 0.0 | 0.0 | 0.0 | 1.0 | 0.0 | — |
| Net Income | |||||||||||||||
| Net Income | (24.4) | (19.1) | (16.2) | (18.5) | (13.8) | (8.0) | 0.8 | (3.3) | (9.1) | (6.2) | (0.6) | (6.7) | 6.0 | 0.2 | (0.3) |
| Per Share | |||||||||||||||
| Basic EPS | (0.41) | (0.63) | (1.17) | (2.15) | (33.16) | (23.74) | 0.06 | (0.25) | (0.68) | — | 0.00 | (0.05) | 0.05 | 0.00 | — |
| Diluted EPS | (0.41) | (0.63) | (1.17) | (2.15) | (33.16) | (23.74) | 0.06 | (0.25) | (0.68) | (0.49) | — | (0.05) | 0.05 | 0.00 | — |
| Revenue per Share | 1.23 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 59.9 | 30.3 | 19.1 | 12.0 | 1.9 | 0.7 | 13.3 | 13.3 | 13.3 | 12.8 | 12.6 | 125.6 | 125.6 | 106.7 | — |
| Diluted Weighted Avg Shares | 59.9 | 30.3 | — | — | 1.9 | 0.7 | 13.3 | 13.3 | 13.3 | — | 125.6 | 125.6 | 125.8 | 106.7 | — |
| Supplemental | |||||||||||||||
| EBITDA | — | (15.3) | (14.3) | (21.2) | (7.3) | (4.1) | 3.1 | 0.1 | — | — | — | — | — | — | — |
| EBIT | (18.3) | (16.7) | (15.5) | (21.8) | (7.5) | (4.5) | 2.7 | (0.3) | (1.2) | (4.9) | (0.2) | (0.4) | 7.1 | 0.3 | (0.3) |
| Effective Tax Rate | — | — | — | 0.0% | 5.9% | -1.5% | -31.5% | -5.9% | 0.2% | -0.0% | -0.1% | -0.0% | 14.2% | 13.9% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.